A Randomized, prospektivE pilot triAL on exercising during treatment in FItting TransplaNt Eligible patientS with Symptomatic multiple myeloma

Not Applicable

Recruiting

• Conditions: C90.0; Multiple myeloma

• Registration Number: DRKS00022250
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

(1) Symptomatic MM at inital diagnosis. (2) Planned induction therapy with VCD followed by transplantation at UKF.

Exclusion Criteria

(1) Spinal cord compression or unstable fractures. (2) Severe cardial diseases or arrythmia (NYHAE 3-4). (3) Chronic cardial diseases (NYHAE 3-4). (4) Other severe diseases not allowing physical activity and exercising (e. g. severe neurological disorder).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility with ist aim of a multicentric, randomised clinical trial.

Secondary Outcome Measures

Name	Time	Method
(1) Evaluation of Revised Myeloma Comorbiditiy Index (R-MCI) due to differences in physical active vs. inactive MM-patients. (2) Event Free Survival (EFS).